Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 13:15:30 +0200Fri, 28 Jun 2024 16:25:00 +0200Human medicines European public assessment report (EPAR): Xerava, eravacycline, Date of authorisation: 20/09/2018, Revision: 8, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xeravaHuman medicines European public assessment report (EPAR): Xerava, eravacycline, Date of authorisation: 20/09/2018, Revision: 8, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xeravaFri, 28 Jun 2024 16:25:00 +0200Human medicineXerava : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-004237-en.pdfXerava : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-004237-en.pdfFri, 28 Jun 2024 16:21:00 +0200Human medicine